Tepezza, a drug used to treat thyroid eye disease (TED), has been at the center of numerous lawsuits in Connecticut. Plaintiffs in these Tepezza lawsuits claim that the drug caused hearing loss and tinnitus and that Horizon Therapeutics failed to provide adequate warnings about the potential risks.
This post will provide insights into the accusations against the manufacturer, possible consequences of using Tepezza, and legal routes for victims of related hearing damage. Prepare to navigate the intricate landscape of Connecticut Tepezza hearing loss and tinnitus lawsuits.
If you or someone you care about has experienced the effects of Tepezza and faced challenges like hearing loss, the committed professionals at Schmidt & Clark, LLP are ready to assist. We are a nationally renowned law firm that specializes in representing plaintiffs, and our main goal is to secure the justice and compensation that you rightfully deserve.
Connecticut Tepezza Lawsuit
Tepezza is a medication specifically designed to treat thyroid eye disease (TED). It is an effective remedy for this condition. It was granted FDA approval in January 2020 and developed by Horizon Therapeutics.
However, multiple lawsuits have been filed against Horizon Therapeutics, alleging that the drug caused permanent hearing loss and tinnitus in some patients. The plaintiffs argue that the manufacturer did not provide enough warning about the potential for hearing damage associated with Tepezza and misled people about the drug's link to long-term hearing issues.
Recent developments in the Tepezza hearing loss lawsuits have seen the cases combined into one multidistrict litigation in the Northern District of Illinois. The Judicial Panel on Multidistrict Litigation made this decision to streamline the legal process, allowing for a more efficient resolution of the cases.
Plaintiffs' Claims and Horizon's Defense
The plaintiffs in the Tepezza hearing loss lawsuits allege that Horizon Therapeutics failed to provide adequate warnings about the risks of hearing loss and misled people about the drug's connection to long-term hearing issues.
They claim that the manufacturer did not conduct enough research on the drug and its potential side effects before releasing it to the market. As a result, many patients who took Tepezza for thyroid eye disease experienced unexpected and devastating hearing-related side effects.
Horizon Therapeutics has responded by filing a Motion to Dismiss. They argue that the plaintiff's failure to warn claims should be dismissed as they are subject to the federal preemption doctrine.
They assert that the warning labels on Tepezza are regulated by federal law and regulations, which supersede state law tort claims. The outcome of this legal battle will depend on the strength of the plaintiff's claims and the success of Horizon's defense strategy.
Recent Developments in Tepezza Hearing Loss Lawsuits
As mentioned earlier, the Judicial Panel on Multidistrict Litigation has combined the Tepezza hearing damage lawsuits into one multidistrict litigation in the Northern District of Illinois.
This decision aims to streamline the legal process and achieve a more efficient resolution of the cases. The actions taken in the multidistrict litigation include:
- Combining all the Tepezza hearing damage lawsuits into one case
- Assigning a magistrate judge to handle the discovery process
- Granting the magistrate judge the power to change the discovery deadline
- Overseeing the settlement conference
Additionally, the preliminary status hearing for the Tepezza class action is scheduled for September 19, 2023, at 9:15 a.m. This hearing will provide an opportunity for both parties to present their arguments and update the court on the progress of their cases.
With the ongoing legal proceedings, it remains to be seen how the Tepezza hearing loss lawsuits will unfold and what the potential outcomes may be for those affected by the drug's side effects.
What Is Tepezza?
Tepezza is a medication prescribed to manage thyroid eye disease (TED). It is a rare autoimmune condition that affects the tissues surrounding the eyes, resulting in swelling and potential damage . The drug works by inhibiting the activity of IGF-1R. This receptor is believed to have a role in TED's development.
Tepezza received FDA approval in January 2020 and was developed by Horizon Therapeutics. While the drug has been successful in treating TED, some patients have experienced hearing loss and tinnitus as side effects, leading to ongoing lawsuits in Connecticut.
Tepezza Side Effects & Hearing Loss
Tepezza has been linked to several side effects, including:
- Hearing-related adverse events occurred in around 9.5 percent of people taking the drug.
- The FDA took action in July 2023 to update the warning labels on Tepezza, detailing the potential risk of permanent hearing impairment or loss.
- This has raised concerns about the safety of the drug and has led to the filing of multiple lawsuits against Horizon Therapeutics by patients who experienced hearing loss or tinnitus after receiving Tepezza treatment.
Research and studies have shown a connection between Tepezza and hearing loss. A case series in January 2022 reported four cases of Tepezza-associated hearing loss, while a report published in February 2022 found that three out of five patients with Tepezza-related hearing loss had persistent subjective hearing loss at their last follow-up.
These findings have contributed to the ongoing debate surrounding Tepezza's safety and the potential risks associated with its use.
Does Tepezza Cause Hearing Problems?
Tepezza does cause hearing problems. Several studies and research papers have established a link between Tepezza and hearing loss or tinnitus . One such study published in 2021 found that 81.5 percent of patients developed new hearing symptoms after receiving approximately four infusions of Tepezza.
These findings have raised concerns about the safety of Tepezza and its potential to cause hearing problems in patients.
Despite these alarming findings, more research is needed to conclusively establish the causal link between Tepezza and hearing loss or tinnitus. Meanwhile, doctors are advised to screen patients with hearing tests before and during Tepezza treatment to monitor any changes in their hearing abilities.
"65% of patients on Tepezza reported permanent hearing damage. The hearing problems from Tepezza appeared to develop after an average of 3.6 infusions, according to the findings."- The Endocrine Society
Potential Settlements and Compensation in Connecticut Tepezza Lawsuits
The potential settlements and compensation for plaintiffs in the Connecticut Tepezza hearing loss lawsuits can vary greatly. Estimates suggest that if a case has favorable facts, the potential settlement value could range from $140,000 to $350,000.
It is important to note, however, that there is currently no settlement or compensation program in place for people affected by Tepezza hearing loss or tinnitus.
The amount of compensation awarded in Tepezza lawsuits will depend on the individual details of each case. Factors such as the severity of the injury, the impact on the patient's quality of life, and the strength of the evidence presented will all influence the potential settlement value.
Who Qualifies to File a Connecticut Tepezza Lawsuit?
Individuals who have suffered hearing loss or ringing in the ears due to taking Tepezza or their loved ones qualify to file a Connecticut Tepezza lawsuit.
To be eligible for filing a Tepezza hearing loss lawsuit in Connecticut, you must meet the following criteria:
- Have received Tepezza treatment for thyroid eye disease, Graves' eye disease, Graves' ophthalmopathy, or Graves' orbitopathy, all of which are related to Graves disease
- Experienced hearing loss or damage after the treatment
- Have no history of hearing loss before the treatment
- Be diagnosed with hearing loss or tinnitus after receiving Tepezza treatment.
If you or someone close to you has experienced hearing-related side effects after receiving Tepezza treatment, consult with a lawyer specializing in pharmaceutical litigation to explore your legal options.
Filing a Connecticut Tepezza Hearing Loss Lawsuit
If contemplating filing a Tepezza hearing loss lawsuit in Connecticut, adhering to the correct legal procedure is paramount. Here are the steps to follow:
- Consult a lawyer specializing in pharmaceutical litigation to review your case.
- Gather evidence linking your hearing loss or tinnitus to Tepezza.
- File a lawsuit against Horizon Therapeutics.
- Collaborate with a seasoned legal team to secure the most favorable outcome for your case.
Filing a Tepezza lawsuit requires meeting certain eligibility criteria. This entails no prior history of hearing loss and a diagnosis of hearing loss or tinnitus post-Tepezza treatment.
If you meet these criteria, you may be eligible to join the ongoing Tepezza hearing loss lawsuits in Connecticut. Prompt action is necessary due to potential time constraints for filing a lawsuit, subject to your state's statute of limitations.
Statute of Limitations in Connecticut
The statute of limitations in Connecticut varies depending on the type of case. Here are the time limits for different types of cases:
- For most civil cases, such as personal injury, libel, and fraud, you have two or three years to file a lawsuit.
- For most crimes, prosecutors have up to five years to initiate legal proceedings.
- However, for Class A felonies or offenses involving sexual abuse, exploitation, or assault, there is no time limit.
Consulting a lawyer proficient in pharmaceutical litigation is imperative to ensure filing your Tepezza hearing loss lawsuit within your state's applicable statute of limitations.
See all related dangerous drug lawsuits our attorneys covered so far.
Get a Free Case Evaluation From Connecticut Tepezza Lawyers
At Schmidt and Clark, LLP we stand by your side when you need it most. If you or a loved one has faced challenges related to Tepezza, we encourage you to contact us without hesitation. Our team brings extensive experience in handling such cases and is dedicated to supporting you every step of the way.
You have the right to be well-informed about your legal rights and the potential for a lawsuit. It's important to note that our consultations are always provided free of charge, and you won't have any financial obligations unless we secure a favorable outcome for your case. Our commitment is to serve you with the same compassion and dedication we would offer to our own families.
Don't hesitate to reach out to Schmidt and Clark today for a comprehensive case evaluation. Let us be your trusted partner on this legal journey.